Pharmatech Associates adds Dr. Praveen Tyle to Board of Trustees

Roche receives USFDA’s priority review to Xolair for food allergies based on positive NIH Phase III study results

If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure

Abbott India MD Vivek Kamath resigns

His resignation would be effective from March 18, 2024

AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access

Currently, Venkat is Lead – Market Access, India at Pfizer

Zydus appoints Punit Patel as President and CEO, Americas

Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace

Federal Bank Hormis Memorial Foundation, Tata Trusts and News18 join hands to launch ‘Sanjeevani’

‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic

Aptar appoints Sarah Glickman to its Board of Directors

Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.

Sandoz plans to build a Biosimilar Technical Development Center in Slovenia

Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026

Eugia Pharma signs voluntary license with Medicines Patent Pool to develop generic version of Nilotinib Capsules

The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India

Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData

The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab